HCPCS code lookup
HCPCS Level II
Q2054
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Ask Rivvi
- Code
- Q2054
- Description
- Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
NDC crosswalk
- 73153-0900-01 Breyanzi, Juno Therapeutics, Inc.. Billable units per 11-digit NDC: 1.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.